Moleculin Announces Additional Annamycin Patent Allowances to Enhance Global Exclusivity
March 6, 2025
Biotechnology
-
-
Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
March 6, 2025
-
Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark
March 6, 2025
-
TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company
March 5, 2025
-
Lisata Therapeutics and GATC Health Consummate First Step in Strategic Collaboration to use AI to Derisk and Accelerate Drug Development
March 5, 2025
-
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
March 5, 2025
-
Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences
March 3, 2025
-
Akari Therapeutics Announces $7.6 Million Private Placement Offering Led by Existing Shareholders and Insiders Priced at the Market Under Nasdaq Rules
March 3, 2025
-
Sonnet BioTherapeutics Presents Compilation of Data Highlighting the Potential of SON-1010 as a Monotherapy or a Combination Therapy to Improve the Treatment of Solid Tumors
February 26, 2025
-
MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer
February 26, 2025
-
Scorpius Holdings Engages Alliance Global Partners to Explore Strategic Alternatives
February 26, 2025
-
PDS Biotech Announces Positive Clinical Data Demonstrating Compelling Survival and Clinical Responses in Recurrent/Metastatic HPV-Associated Cancers Published in JAMA Oncology
February 26, 2025
-
Karyopharm Announces 1-for-15 Reverse Stock Split
February 24, 2025
-
Agenus Presents New Botensilimab/Balstilimab Data in Gastric Cancer at AACR IO Annual Meeting
February 24, 2025
-
Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment
February 11, 2025
-
Oncocyte Prices $29.1 Million Equity Offering
February 10, 2025